CME - CIK 0001156375
The table below shows CME GROUP INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $4.28B | $3.69B | $3.45B | $3.06B | $2.40B | $2.72B |
| Capital expenditure | $83.50M | $94.00M | $76.40M | $89.70M | $127.20M | $197.50M |
| Investing cash flow | $1.50B | -$82.60M | $20.90M | -$489.80M | $58.40M | -$175.50M |
| Dividends paid | $3.93B | $3.58B | $3.24B | $2.63B | $2.19B | $2.11B |
CME GROUP INC. reported operating cash flow of $4.28B for fiscal year 2025. That is up 15.9% from $3.69B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.73B (FY 2016) to $4.28B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $56.51B | $5.08B | -$48.34B | -$25.38B | $69.91B | $47.25B |